Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc. scores highest on Nitro (72) and lowest on Earnings (16). Its PosiPenta is 40.18 out of 100, around the middle of similar companies.
On the Penta Grid this week, Eupraxia Pharmaceuticals Inc. is Grid #8 of 11 in the Healthcare sector in Canada, and Grid #180 of 220 in Canada.
Compared with similar companies in the Healthcare sector in Canada.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Eupraxia Pharmaceuticals Inc. | 40.18 | 18 | 16 | 72 | 45 | 50 |
| Cipher Pharmaceuticals Inc. | 64.27 | 71 | 59 | 44 | 76 | 72 |
| Organigram Global Inc. | 57.94 | 91 | 54 | 29 | 66 | 49 |
| BioSyent Inc. | 66.13 | 41 | 56 | 93 | 67 | 74 |
| Medexus Pharmaceuticals Inc. | 49.04 | 24 | 50 | 88 | 44 | 40 |
| BriaCell Therapeutics Corp. | 33.22 | 38 | 31 | 23 | 43 | 31 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -7.08 |
| P/B ratio | 3.58 |
EEarnings
| Trailing EPS | ₹-95.82 |
| Forward EPS | ₹-99.59 |
NNitro
| Price | 678.23 |
| 52-week high | 888.90 |
| 52-week low | 499.50 |
| Fall from 52-week high | 23.7% |
TTorque
| Return on equity (ROE) | -66.70% |
| Debt-to-equity | 0.01 |
AAnchor
| Beta (price swings) | 1.22 |
| Market cap | ₹4,481 Cr |
| Insider holding | 12.11% |
| Dividend yield | 0.00% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Eupraxia Pharmaceuticals Inc.'s PosiPenta score?
Eupraxia Pharmaceuticals Inc.'s PosiPenta is 40.18 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Eupraxia Pharmaceuticals Inc. stand on the Penta Grid?
On the Penta Grid this week, Eupraxia Pharmaceuticals Inc. is Grid #8 of 11 in the Healthcare sector in Canada, and Grid #180 of 220 in Canada.
Which PosiPenta pillar is strongest for Eupraxia Pharmaceuticals Inc.?
Nitro (momentum), with a score of 72 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Eupraxia Pharmaceuticals Inc.?
Earnings (growth), with a score of 16 out of 100: much weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.